The company, which is primarily a marketplace for secondary ticket sales, has plenty of demand for its offering that could raise as much as $851 million. The deal, which prices late on Tuesday, is ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, ...